Ten63 Therapeutics CEO Marcel Frenkel (L) and chairman Clay Thorp

Durham start­up rais­es Se­ries A to tack­le un­drug­gable pro­teins, in­clud­ing can­cer bad­die Myc, with gen­er­a­tive AI

The num­ber of ways atoms can be arranged to cre­ate po­ten­tial drugs is so large — 1063, by one es­ti­mate — that it ex­ceeds the num­ber of stars in the uni­verse. It’s a num­ber too vast for sci­en­tists to ever search through, at least on their own.

But a small start­up spun out of Duke Uni­ver­si­ty hopes that a lit­tle help from AI could change that.

Ten63 Ther­a­peu­tics raised $15.9 mil­lion in Se­ries A fi­nanc­ing led by Hat­teras Ven­ture Part­ners, the start­up an­nounced Tues­day. Co-founder and CEO Mar­cel Frenkel told End­points News that his com­pa­ny will ex­plore pos­si­ble struc­tures for small mol­e­cule drugs “at a scale that has nev­er been done be­fore.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.